日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

The Chinese Society of Clinical Oncology (CSCO): Clinical guidelines for the diagnosis and treatment of colorectal cancer, 2024 update

中国临床肿瘤学会(CSCO):结直肠癌诊疗临床指南(2024年更新版)

Wang, Feng; Chen, Gong; Zhang, Zhen; Yuan, Ying; Wang, Yi; Gao, Yuan-Hong; Sheng, Weiqi; Wang, Zixian; Li, Xinxiang; Yuan, Xianglin; Cai, Sanjun; Ren, Li; Liu, Yunpeng; Xu, Jianmin; Zhang, Yanqiao; Liang, Houjie; Wang, Xicheng; Zhou, Aiping; Ying, Jianming; Li, Guichao; Cai, Muyan; Ji, Gang; Li, Taiyuan; Wang, Jingyu; Hu, Hanguang; Nan, Kejun; Wang, Liuhong; Zhang, Suzhan; Li, Jin; Xu, Rui-Hua

Fecal immunochemical test surveillance in colorectal cancer following adenoma resection: A longitudinal, population-based linked cohort study in China

结直肠腺瘤切除术后粪便免疫化学检测监测:一项中国人群纵向队列研究

Zhao, Jianhui; Liu, Chengcheng; Yang, Jinhua; Huang, Yanqin; Xu, Liying; Xiao, Qian; Jin, Mingjuan; Kong, Xiangxing; Hu, Yeting; Li, Qilong; Zhang, Suzhan; Li, Xue; Zheng, Shu; Chen, Kun; Ding, Kefeng

Upper tract urothelial carcinoma in crossed fused renal ectopia: Case report and review of the literature

交叉融合性肾异位合并上尿路尿路上皮癌:病例报告及文献复习

Bai, Xiaoxuan; Lv, Suzhan; Liu, Dan; Liu, Yuexin; Ping, Hao

Progression from ductal carcinoma in situ to invasive breast cancer: molecular features and clinical significance

导管原位癌向浸润性乳腺癌的进展:分子特征和临床意义

Wang, Jing; Li, Baizhou; Luo, Meng; Huang, Jia; Zhang, Kun; Zheng, Shu; Zhang, Suzhan; Zhou, Jiaojiao

Expression profiles and gene set enrichment analysis of the transcriptomes from the cancer tissue, white adipose tissue and paracancer tissue with colorectal cancer

对结直肠癌癌组织、白色脂肪组织和癌旁组织转录组的表达谱和基因集富集分析

Zhang, Xiufeng; Zhu, Rui; Jiao, Ye; Simayi, Halizere; He, Jialing; Shen, Zhong; Wang, Houdong; He, Jun; Zhang, Suzhan; Yang, Fei

Sintilimab plus bevacizumab, oxaliplatin and capecitabine as first-line therapy in RAS-mutant, microsatellite stable, unresectable metastatic colorectal cancer: an open-label, single-arm, phase II trial

信迪利单抗联合贝伐珠单抗、奥沙利铂和卡培他滨作为RAS突变、微卫星稳定、不可切除的转移性结直肠癌一线治疗方案:一项开放标签、单臂II期试验

Fang, Xuefeng; Zhu, Ning; Zhong, Chenhan; Wang, Liuhong; Li, Jun; Weng, Shanshan; Hu, Hanguang; Dong, Caixia; Li, Dan; Song, Yongmao; Xu, Dong; Wang, Jianwei; Sun, Lifeng; Wang, Jian; Wang, Zhanhuai; Cao, Hongfeng; Liao, Xiujun; Yu, Ningjuan; Xiao, Qian; Mi, Mi; Zhang, Suzhan; Ding, Kefeng; Yuan, Ying

Dual targeted therapy with pyrotinib and trastuzumab for HER2-positive advanced colorectal cancer: A phase 2 trial

采用吡咯替尼和曲妥珠单抗进行双靶向治疗 HER2 阳性晚期结直肠癌:一项 II 期试验

Fu, Xianhua; Ying, Jieer; Yang, Liu; Fang, Weijia; Han, Weidong; Hu, Hanguang; Zhang, Suzhan; Yuan, Ying

Sintilimab plus bevacizumab and CapeOx (BBCAPX) on first-line treatment in patients with RAS mutant, microsatellite stable, metastatic colorectal cancer: study protocol of a randomized, open-label, multicentric study

信迪利单抗联合贝伐珠单抗和卡培他滨(BBCAPX)一线治疗RAS突变、微卫星稳定型转移性结直肠癌患者:一项随机、开放标签、多中心研究的研究方案

Fang, Xuefeng; Zhong, Chenhan; Weng, Shanshan; Hu, Hanguang; Wang, Jian; Xiao, Qian; Wang, Jianwei; Sun, Lifeng; Xu, Dong; Liao, Xiujun; Dong, Caixia; Zhang, Suzhan; Li, Jun; Ding, Kefeng; Yuan, Ying

A prognostic signature associated with cell senescence predicts survival outcomes and strongly associates with immunotherapy and chemotherapy response in breast cancer

与细胞衰老相关的预后特征可预测生存结果,并与乳腺癌的免疫治疗和化疗反应密切相关。

Pan, Tao; Hu, Zhengfang; Xu, Dongyan; Zhou, Yunxiang; Zhang, Suzhan; Chen, Yiding

CSCO guidelines for colorectal cancer version 2022: Updates and discussions

CSCO 结直肠癌诊疗指南 2022 版:更新与讨论

Yuan, Zhijun; Weng, Shanshan; Ye, Chenyang; Hu, Hanguang; Zhang, Suzhan; Yuan, Ying